TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LFCR

Lifecore Biomedical Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

4.50$ +7.2% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Lifecore Biomedical Inc. (LFCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.1% of the shares are freely tradable; institutional investors hold 77.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 77.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 51.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 38Mio.

Largest Shareholders

Institutions

Institutions LFCR
Name Stake (%) Shares Change (%) Date
Wynnefield Capital Inc 12.42 4,703,216 +0.0 06/30/2026
Legion Partners Asset Management, LLC 11.79 4,461,823 +0.0 06/30/2026
Greenhaven Road Investment Management, L.P. 9.35 3,537,573 -3.9 03/31/2026
325 Capital LLC 7.65 2,895,881 +33.9 06/30/2026
BlackRock Inc 4.96 1,877,305 -1.6 03/31/2026
Vanguard Capital Management, LLC 3.41 1,290,136 +0.0 03/31/2026
Geode Capital Management, LLC 2.15 815,107 +4.5 03/31/2026
Morgan Stanley - Brokerage Accounts 2.02 764,734 +1.8 03/31/2026

Funds

Funds LFCR
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.17 822,113 +0.0 07/31/2026
iShares Russell 2000 ETF 1.90 718,525 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?